Background: Pancreatic cancer is a highly aggressive solid tumor. Patients with metastases from pancreatic cancer have poor survival rates. Here, we report the outcomes of 6 patients for whom resection of lung metastases was performed after a pancreatectomy to treat pancreatic cancer. Methods: We retrospectively reviewed the perioperative clinical data of patients with lung metastases resulting from primary pancreatic cancer who were treated with lung resection between 2008 and 2015. We report 6 cases where lung resection was performed to treat lung metastases after a pancreatectomy. Results: The number of lung metastases was 1 in 5 cases and 2 in 1 case. The surgical procedures performed to treat the lung metastases included 4 wedge...
INTRODUCTION: Metastases to the pancreas from other primary tumors are increasingly recognized in ...
Copyright © 2014 R. F. Falkenstern-Ge et al. This is an open access article distributed under the Cr...
OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant vari...
Simple Summary With the development of chemotherapy, studies have been conducted on the possibility ...
BACKGROUND AND OBJECTIVES: The incidence of metastases to the pancreas is very low. The benefit of r...
Pancreatic metastases from other primary malignancies are a rare entity. By far, the most common pri...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
Background and objective A number of patients with lung cancer have distant metastases at the time o...
INTRODUCTION: Pancreatic metastasis from several malignancies are increasingly encountered in clin...
Introduction:Little information is available concerning the prognosis and treatment of metastasis-in...
Background: Literature data about pancreatic resections for metastases are limited to small series, ...
Background: The literature suggests favorable survival for patients with isolated pulmonary recurren...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
BACKGROUND: Surgical resection of pancreatic metastasis (PM) is the only reported curative treatment...
Because the prognosis of the patients with pancreatic cancer is very poor, there are few opportuniti...
INTRODUCTION: Metastases to the pancreas from other primary tumors are increasingly recognized in ...
Copyright © 2014 R. F. Falkenstern-Ge et al. This is an open access article distributed under the Cr...
OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant vari...
Simple Summary With the development of chemotherapy, studies have been conducted on the possibility ...
BACKGROUND AND OBJECTIVES: The incidence of metastases to the pancreas is very low. The benefit of r...
Pancreatic metastases from other primary malignancies are a rare entity. By far, the most common pri...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
Background and objective A number of patients with lung cancer have distant metastases at the time o...
INTRODUCTION: Pancreatic metastasis from several malignancies are increasingly encountered in clin...
Introduction:Little information is available concerning the prognosis and treatment of metastasis-in...
Background: Literature data about pancreatic resections for metastases are limited to small series, ...
Background: The literature suggests favorable survival for patients with isolated pulmonary recurren...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
BACKGROUND: Surgical resection of pancreatic metastasis (PM) is the only reported curative treatment...
Because the prognosis of the patients with pancreatic cancer is very poor, there are few opportuniti...
INTRODUCTION: Metastases to the pancreas from other primary tumors are increasingly recognized in ...
Copyright © 2014 R. F. Falkenstern-Ge et al. This is an open access article distributed under the Cr...
OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant vari...